Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-02 Sale | 2023-06-06 5:07 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 192,221 | $33.7 | $6,478,587 | 806,831 (Indirect Direct) | View |
| 2023-03-28 Sale | 2023-03-30 5:52 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 112,779 | $37.06 | $4,179,295 | 1,119,052 (Indirect Direct) | View |
| 2023-02-23 Sale | 2023-02-27 7:14 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 25,000 | $37.27 | $931,658 | 1,231,831 (Indirect Direct) | View |
| 2022-11-21 Sale | 2022-11-22 5:29 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 40,000 | $43.14 | $1,725,567 | 1,126,831 (Indirect Direct) | View |
| 2022-11-10 Sale | 2022-11-14 5:13 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 50,000 | $43.85 | $2,192,613 | 1,568,538 (Indirect Direct) | View |
| 2022-08-09 Sale | 2022-08-11 5:02 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 20,854 | $43.92 | $915,909 | 1,357,945 (Indirect Direct) | View |
| 2022-07-28 Sale | 2022-08-01 5:01 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 4,046 | $43.97 | $177,893 | 1,378,799 (Indirect Direct) | View |
| 2022-07-25 Sale | 2022-07-27 6:20 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 75,100 | $43.25 | $3,248,199 | 1,002,845 (Indirect Direct) | View |
| 2022-05-26 Sale | 2022-05-31 5:19 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 100,000 | $40.29 | $4,029,091 | 1,446,831 (Indirect Direct) | View |
| 2022-05-23 Sale | 2022-05-25 5:10 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 100,000 | $40.27 | $4,026,770 | 1,546,831 (Indirect Direct) | View |
| 2021-11-16 Sale | 2021-11-18 7:18 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 250,000 | $42.39 | $10,596,693 | 1,593,556 (Indirect Direct) | View |
| 2021-07-26 Sale | 2021-07-27 5:29 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 13,362 | $39.78 | $531,532 | 1,300,960 (Indirect Direct) | View |
| 2021-07-12 Sale | 2021-07-14 5:18 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 23,149 | $42.01 | $972,456 | 1,309,409 (Indirect Direct) | View |
| 2021-07-06 Sale | 2021-07-08 7:36 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 88,489 | $42.19 | $3,733,762 | 1,327,490 (Indirect Direct) | View |
| 2021-06-10 Sale | 2021-06-14 6:42 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 70,000 | $46.49 | $3,254,369 | 520,960 (Indirect Direct) | View |
| 2021-06-04 Sale | 2021-06-08 8:12 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 252,500 | $46.01 | $11,616,797 | 530,960 (Indirect Direct) | View |
| 2021-06-02 Sale | 2021-06-04 6:48 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 62,500 | $42.12 | $2,632,513 | 1,626,960 (Indirect Direct) | View |
| 2021-04-14 Sale | 2021-04-16 5:57 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 69,822 | $42.13 | $2,941,920 | 476,960 (Indirect Direct) | View |
| 2021-04-12 Sale | 2021-04-14 07:52 am | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 449 | $42.32 | $19,002 | 532,858 (Indirect Direct) | View |
| 2021-03-22 Sale | 2021-03-24 5:25 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 54,729 | $46.32 | $2,535,226 | 533,218 (Indirect Direct) | View |
| 2021-03-02 Sale | 2021-03-04 7:03 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 125,000 | $46.94 | $5,867,148 | 576,960 (Indirect Direct) | View |
| 2020-06-18 Purchase | 2020-06-22 9:54 pm | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 14,200 | $28 | $397,600 | 1,348,411 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-12 Gift | 2024-08-12 7:19 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 7,920 | $0 | 408,232 (Direct) | View |
| 2023-11-13 Conversion | 2023-11-14 7:35 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 165,000 | $0 | 1,412,983 (Indirect) | View |
| 2023-08-08 Gift | 2023-08-08 5:36 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 5,555 | $0 | 431,152 (Direct) | View |
| 2022-08-12 Gift | 2022-11-14 5:13 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO | 5,889 | $0 | 1,568,538 (Direct) | View |
| 2021-09-10 Gift | 2021-11-18 7:18 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 1,282 | $0 | 1,593,556 (Direct) | View |
| 2021-05-07 Conversion | 2021-05-11 9:05 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 2,063,446 | $0 | 1,020,838 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:43 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 550,000 | $0 | 1,315,035 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:54 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 1,069,401 | $0 | 1,348,411 (Direct) | View |
| 2020-06-18 Conversion | 2020-06-22 9:54 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 289,036 | $0 | 1,348,411 (Indirect) | View |
Ownership | 2020-06-15 9:20 pm | N/A N/A | Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC | 0 | $0 | 7,517,010 (Direct) | View |